Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock

EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS) (“Amyris”), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.
Amyris Logo (PRNewsfoto/Amyris, Inc.)
Amyris is conducting a resale of stock on behalf of its current stockholders, DSM International…

Click here to view the original article.